Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Amcinonide products are in shortage in Canada (3 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A topical corticosteroid used to reduce skin inflammation and itching.
Products affected
3 / 7
In shortage since
May 17, 2017
Reports on file
16
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
RATIO-AMCINONIDE
0.1% · OINTMENT · TEVA CANADA LIMITED
DIN 02247096 · since Jul 30, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RATIO-AMCINONIDE
0.1% · CREAM · TEVA CANADA LIMITED
DIN 02247098 · since Jul 30, 2017, no end estimate · Disruption of the manufacture of the drug.
Active shortage
RATIO-AMCINONIDE
0.1% · LOTION · TEVA CANADA LIMITED
DIN 02247097 · since May 17, 2017, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended Aug 5, 2021 · Disruption of the manufacture of the drug.
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended May 19, 2021 · Disruption of the manufacture of the drug.
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended Jul 31, 2020 · Disruption of the manufacture of the drug.
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended May 8, 2020 · Disruption of the manufacture of the drug.
Discontinued
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714
Resolved
CYCLOCORT
0.1% · LOTION · GLAXOSMITHKLINE INC
DIN 02192276 · ended Sep 14, 2017 · Disruption of the manufacture of the drug.
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended Oct 17, 2018 · Disruption of the manufacture of the drug.
Resolved
TARO-AMCINONIDE
0.1% · CREAM · TARO PHARMACEUTICALS INC
DIN 02246714 · ended Oct 17, 2018 · Disruption of the manufacture of the drug.
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
Amcinonide is currently affected by 3 active shortage reports filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Amcinonide is classified under “CORTICOSTEROIDS, PLAIN” (ATC D07AC).
Recent changes
No changes recorded yet.
Common questions
What is Amcinonide used for?
A topical corticosteroid used to reduce skin inflammation and itching.
When will Amcinonide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Amcinonide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.